M.D. student at The Institute of Mental Health, Second Xiangya Hospital, Central South University, China
Profile:
ScopusΒ
Education:
Qianjin Wang has pursued a distinguished academic career in the field of psychiatry. He is currently completing his Doctor of Medicine (M.D.) at Central South University, Xiangya School of Medicine, with an expected graduation in 2024. His dissertation, “Resting-state Functional MRI Study Before and After Medication Treatment in First-Episode Depression Patients,” under the guidance of Professor Tieqiao Liu, explores the intricate changes in brain function associated with depression treatment.Prior to his doctoral studies, Qianjin earned his Master of Medicine (M.M.) from the same institution between 2017 and 2020. His master’s thesis, “Neuroimaging and Clinical Features of Methamphetamine Dependence,” supervised by Professor Yanhui Liao, focused on the neurological and clinical aspects of substance dependence, contributing valuable insights to the field.Qianjin’s academic journey began with a Bachelor of Medicine (B.M.) degree from Central South University, Xiangya School of Medicine, completed in 2017. His senior project, “Clinical Characteristics and Treatment Strategies for Major Depressive Disorder,” also supervised by Professor Yanhui Liao, laid the foundation for his future research endeavors.Throughout his education, Qianjin has demonstrated a strong commitment to advancing psychiatric research, leveraging advanced neuroimaging techniques, and contributing to the understanding and treatment of mental health disorders. π§ π
Professional skills:
Qianjin Wang is proficient in various clinical statistical analysis methodologies, including clinical prediction models, mediation analysis, and cluster analysis. He is skilled in using statistical software such as SPSS, R, Matlab, and GraphPad Prism. Qianjin is also well-versed in the process of writing and submitting research proposals and scientific papers. He has participated in several drug trial studies, notably the “Naltrexone Implant Antagonist Efficacy of Opioid Agonist Hydromorphone Randomized, Double-blind, Single-center Clinical Study” and the “Phase II Trial of Duanjin Detox Capsule in Heroin Users.” Since September 2020, Qianjin has been engaged in clinical training at the Department of Psychiatry, Xiangya Second Hospital, Central South University, where he has followed up in the outpatient department and served as chief resident in the male PICU. He is proficient in collecting medical history, conducting physical examinations, making differential diagnoses, and treating common psychiatric diseases. Additionally, he is capable of independently handling psychiatric emergencies and assisting non-psychiatric physicians in managing patients with psychiatric symptoms.
Academic Honors
π 2023 Graduate National Scholarship π
2022 Central South University Graduate Principal Scholarship (Innovation Award) π 2022 Central South University Lianquan Sumitomo Scholarship π 2020-2023 Central South University Graduate Academic Scholarship (First Class, twice; Second Class, once) π 2020-2023 Central South University Outstanding Student Award (twice)
Certifications:
π Qianjin Wang holds a plethora of certifications that underscore his expertise in the medical field:
π¨ββοΈ Medical Practitioner Certificate
π©Ί Physician Qualification Certificate
π₯ Residency Training Certification
π§ Psychiatrist Qualification Certificate
ποΈ Intermediate Qualification in Psychotherapy (Exam Preparation)
π¬ GCP Certificate (Good Clinical Practice)
π CET-4 (College English Test)
π» Computer Level 3 Certificate
π΄ Mandarin Proficiency Certificate
Academic Awards:
π Qianjin Wang has garnered several prestigious academic awards, showcasing his exemplary contributions to the field:
π₯ First Place in Poster Presentation at the 20th Annual Conference of the Chinese Medical Association Psychiatry Branch in 2024. This national recognition, shared among only four recipients, underscores Qianjin’s expertise and innovative research in psychiatry.
π
First Prize for Excellent Youth Paper at the 20th Academic Conference of the China Association for Drug Abuse Prevention and Control in 2021. Among two national recipients, this award highlights Qianjin’s significant contributions to drug abuse prevention and control research.
π₯ First Prize for Outstanding Paper at the 18th Annual Conference of the Chinese Medical Association Psychiatry Branch in 2022. With only four national recipients, this award recognizes Qianjin’s outstanding research and academic achievements in psychiatry.
π₯ Second Prize for Excellent Youth Paper at the 21st Academic Conference of the China Association for Drug Abuse Prevention and Control in 2022, further solidifying Qianjin’s position as a promising young researcher in the field.
π₯ Third Prize at the Youth Research Forum during the 8th Chinese Geriatric Medicine and Technology Innovation Conference Forum and Chinese Geriatric Psychiatry and Mental Health Academic Conference in 2022. This accolade acknowledges Qianjin’s valuable contributions to geriatric psychiatry research and innovation.
Research Β FocusΒ Β :
- Resting-state Functional Connectivity: Investigating alterations in the functional connectivity patterns of brain networks, such as the default mode network and the salience network, in individuals with depression and substance use disorders. This includes examining how changes in connectivity relate to symptom severity, treatment response, and cognitive functioning.
- Neurochemical Abnormalities: Using MRS to measure concentrations of key neurotransmitters and metabolites in regions implicated in depression and substance abuse. This research aims to identify biomarkers that may predict treatment outcomes and aid in developing targeted therapeutic interventions.
- Cognitive Functioning: Examining the relationship between neural dysfunction and cognitive deficits in psychiatric disorders. Qianjin investigates how disruptions in executive function, attention, memory, and emotional processing contribute to the symptomatology and progression of depression and substance use disorders.
- Treatment Effects: Assessing the impact of pharmacological and psychological interventions on brain function and cognitive processes in individuals with psychiatric disorders. This includes evaluating how different treatment modalities modulate neural circuitry and neurochemical levels to promote symptom remission and recovery.
Citations:
π Qianjin Wang’s research has received significant recognition, with 310 citations across 285 documents, highlighting its relevance and impact in the field.
π He has authored or co-authored 48 documents, showcasing the breadth and depth of his scholarly contributions.
ποΈ Qianjin boasts an h-index of 10, indicative of notable recognition for the influence and productivity of his research output.
Publication Top Notes:
Grey Matter Volume Reduction in the Frontotemporal Cortex Associated with Persistent Verbal Auditory Hallucinations in Chinese Patients with Chronic Schizophrenia: Insights from a 3 T Magnetic Resonance Imaging Study
Wang, Q., along with Ren, H., Li, J., Zhou, J., and Li, Z., contributed to this pivotal study published in Schizophrenia Research (2024, 269, pp. 123β129). This research highlighted the reduction of grey matter volume in the frontotemporal cortex of Chinese patients with chronic schizophrenia experiencing persistent verbal auditory hallucinations, utilizing 3T magnetic resonance imaging to provide insights into the structural brain abnormalities associated with these symptoms.
Association of Clinical Variables and Thyroid-Stimulating Hormone with Psychotic Symptoms in Patients with First-Episode and Drug-NaΓ―ve Major Depressive Disorder with Elevated Fasting Blood Glucose: Preliminary Exploratory Study with a Large Sample
Yang, Q., Wang, Q., Peng, P., Liu, T., and Zhang, X. published an exploratory study in BJPsych Open (2024, 10(3), e99). This research investigated the association between clinical variables and thyroid-stimulating hormone levels with psychotic symptoms in patients with first-episode and drug-naΓ―ve major depressive disorder who also had elevated fasting blood glucose.
Association Between Childhood Maltreatment and Suicidal Ideation Anmog Chinese Patients with Chronic Schizophrenia: The Mediating Role of Insomnia
In BJPsych Open (2024, 10(3), e98), Hao, Y., Peng, P., Wang, Q., Liu, T., and Zhang, X. explored the impact of childhood maltreatment on suicidal ideation in Chinese patients with chronic schizophrenia, focusing on the mediating role of insomnia. This study provided valuable insights into the psychological sequelae of childhood trauma in schizophrenia.
Polysomnographic Features of Insomnia Occurring in Major Depressive Disorder, Generalized Anxiety Disorder, and Bipolar Mania: Comparison with Primary Insomnia and Association with Metabolic Indicators
Xu, X., Wang, Q., Zhang, Z., Liu, T., and Tan, L. published their findings in the Journal of Affective Disorders (2024, 351, pp. 449β457). Their study compared the polysomnographic features of insomnia in various psychiatric disorders with primary insomnia, examining associations with metabolic indicators.
Serial Multiple Mediating Roles of Anxiety and Thyroid-Stimulating Hormone in the Relationship Between Depression and Psychotic Symptoms in Young Adults with Anxious Depression
In this research, Wang, Q., Ren, H., Liu, T., and Zhang, X.-Y. analyzed the mediating roles of anxiety and thyroid-stimulating hormone in the link between depression and psychotic symptoms. Their findings were published in the Journal of Affective Disorders (2024, 351, pp. 8β14).
Altered Spontaneous Neurological Activity in Methamphetamine Use Disorders and Its Association with Cognitive Function
Zhou, Y., Yang, W.F.Z., Wu, Q., Wang, Q., and Liu, T. explored the alterations in spontaneous neurological activity in individuals with methamphetamine use disorders and its correlation with cognitive function. This study was published in the Asian Journal of Psychiatry (2024, 94, 103936).
Association of Subclinical Hypothyroidism with Metabolic Syndrome and Its Components Among Outpatients with First-Episode Drug-NaΓ―ve Major Depressive Disorder: A Large-Scale Cross-Sectional Study
Peng, P., Wang, Q., Zhou, Y., Liu, T., and Zhang, X. contributed to the understanding of the relationship between subclinical hypothyroidism and metabolic syndrome in patients with major depressive disorder. Their study appeared in the European Archives of Psychiatry and Clinical Neuroscience (2024, 274(3), pp. 573β582).
Inter-relationships of Insomnia and Psychiatric Symptoms with Suicidal Ideation Among Patients with Chronic Schizophrenia: A Network Perspective
Published in Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024, 129, 110899), Peng, P., Wang, Q., Zhou, Y., Liu, T., and Zhang, X. analyzed the network inter-relationships between insomnia, psychiatric symptoms, and suicidal ideation in chronic schizophrenia.
The Mediating Effects of Perceived Family Support in the Relationship Between Anxiety and Problematic Smartphone Use: A Cross-Cultural Validation
Long, J., Liu, Y., Wang, Y., Liu, T., and Billieux, J., with contributions from Wang, Q., examined the role of perceived family support in mediating the relationship between anxiety and problematic smartphone use. This research was published in the Journal of Nervous and Mental Disease (2024, 212(2), pp. 76β83).
Employing Bayesian Analysis to Establish a Cut-Off Point and Assess Stigma Prevalence in Substance Use Disorder: A Comprehensive Study of the Chinese Version of the Substance Use Stigma Mechanism Scale
Wang, D., Zhou, Y., Chen, S., Liu, T., and Ma, Y., including Wang, Q., employed Bayesian analysis to study the prevalence of stigma in substance use disorder, as detailed in Social Psychiatry and Psychiatric Epidemiology (2024).